324 related articles for article (PubMed ID: 31685653)
1. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
[TBL] [Abstract][Full Text] [Related]
2. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.
Steuer EL; Kemper LJ; Hlynialuk CJW; Leinonen-Wright K; Montonye ML; Lapcinski IP; Forster CL; Ashe KH; Liu P
J Neurosci; 2022 Jun; 42(23):4737-4754. PubMed ID: 35508385
[TBL] [Abstract][Full Text] [Related]
3. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
[TBL] [Abstract][Full Text] [Related]
4. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
[TBL] [Abstract][Full Text] [Related]
5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
6. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
[TBL] [Abstract][Full Text] [Related]
8. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
9. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.
Eskandari-Sedighi G; Daude N; Gapeshina H; Sanders DW; Kamali-Jamil R; Yang J; Shi B; Wille H; Ghetti B; Diamond MI; Janus C; Westaway D
Mol Neurodegener; 2017 Oct; 12(1):72. PubMed ID: 28978354
[TBL] [Abstract][Full Text] [Related]
10. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
[TBL] [Abstract][Full Text] [Related]
11. Expression of P301L-hTau in mouse MEC induces hippocampus-dependent memory deficit.
Liu X; Zeng K; Li M; Wang Q; Liu R; Zhang B; Wang JZ; Shu X; Wang X
Sci Rep; 2017 Jun; 7(1):3914. PubMed ID: 28634382
[TBL] [Abstract][Full Text] [Related]
12. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.
Koss DJ; Robinson L; Mietelska-Porowska A; Gasiorowska A; Sepčić K; Turk T; Jaspars M; Niewiadomska G; Scott RH; Platt B; Riedel G
Cell Mol Life Sci; 2015 Dec; 72(23):4613-32. PubMed ID: 26070304
[TBL] [Abstract][Full Text] [Related]
13. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
14. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
Komuro Y; Xu G; Bhaskar K; Lamb BT
Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
[TBL] [Abstract][Full Text] [Related]
15. STAT3 ameliorates cognitive deficits by positively regulating the expression of NMDARs in a mouse model of FTDP-17.
Hong XY; Wan HL; Li T; Zhang BG; Li XG; Wang X; Li X; Liu Q; Chen CY; Yang Y; Wang Q; Li SP; Yu H; Wang JZ; Yang XF; Liu GP
Signal Transduct Target Ther; 2020 Dec; 5(1):295. PubMed ID: 33361763
[TBL] [Abstract][Full Text] [Related]
16. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.
Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC
Front Immunol; 2020; 11():293. PubMed ID: 32194553
[TBL] [Abstract][Full Text] [Related]
17. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei.
Dutschmann M; Menuet C; Stettner GM; Gestreau C; Borghgraef P; Devijver H; Gielis L; Hilaire G; Van Leuven F
J Neurosci; 2010 Feb; 30(5):1810-21. PubMed ID: 20130190
[TBL] [Abstract][Full Text] [Related]
18. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
19. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons.
Rodríguez-Martín T; Pooler AM; Lau DHW; Mórotz GM; De Vos KJ; Gilley J; Coleman MP; Hanger DP
Neurobiol Dis; 2016 Jan; 85():1-10. PubMed ID: 26459111
[TBL] [Abstract][Full Text] [Related]
20. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.
Lim J; Balastik M; Lee TH; Nakamura K; Liou YC; Sun A; Finn G; Pastorino L; Lee VM; Lu KP
J Clin Invest; 2008 May; 118(5):1877-89. PubMed ID: 18431510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
